id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-D-6146-0008,FDA,FDA-2017-D-6146,"Footnote 13- Junqueira Adipose Chapter 6 re:  Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use; Guidance for Industry and Food and Drug Administration Staff;  Availability",Supporting & Related Material,Background Material,2020-07-21T04:00:00Z,2020,7,,,2020-07-21T16:40:31Z,,0,0,090000648478bf67
FDA-2017-D-6146-0006,FDA,FDA-2017-D-6146,"Regulatory Considerations for Human Cells, Tissues, and Cellular and
Tissue-Based Products: Minimal Manipulation and Homologous Use;
Guidance for Industry and Food and Drug Administration Staff;  Availability",Notice,Notice of Availability,2020-07-21T04:00:00Z,2020,7,2020-07-21T04:00:00Z,,2020-07-21T16:11:13Z,2020-15718,0,0,090000648478b72b
FDA-2017-D-6146-0009,FDA,FDA-2017-D-6146,"Footnote 14 - Adipose Stem Cells Science Review 2010 re: Regulatory Considerations for Human Cells, Tissues, and Cellular and
Tissue-Based Products: Minimal Manipulation and Homologous Use;
Guidance for Industry and Food and Drug Administration Staff;  Availability",Supporting & Related Material,Background Material,2020-07-21T04:00:00Z,2020,7,,,2020-07-21T16:40:47Z,,0,0,090000648478bf68
FDA-2017-D-6146-0007,FDA,FDA-2017-D-6146,"Regulatory Considerations for Human Cells, Tissues, and Cellular and
Tissue-Based Products: Minimal Manipulation and Homologous Use;
Guidance for Industry and Food and Drug Administration Staff;  Availability",Other,Guidance,2020-07-21T04:00:00Z,2020,7,2020-07-21T04:00:00Z,,2024-11-06T23:38:25Z,,1,0,090000648478bf65
FDA-2017-D-6146-0003,FDA,FDA-2017-D-6146,"Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use; Guidance for Industry and Food and Drug Administration Staff",Other,Guidance,2017-12-12T05:00:00Z,2017,12,2017-12-12T05:00:00Z,,2024-11-07T01:14:17Z,,1,0,0900006482d00e87
FDA-2017-D-6146-0001,FDA,FDA-2017-D-6146,"Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use; 
Guidance for Industry and Food and Drug Administration Staff; 
Availability",Rule,Approval,2017-11-17T05:00:00Z,2017,11,2017-11-17T05:00:00Z,,2017-11-17T19:42:40Z,2017-24838,0,0,0900006482c8a3fa
FDA-2017-D-6146-0002,FDA,FDA-2017-D-6146,"Guidance for Industry on Regulatory Considerations for Human Cell, Tissues, and Cellular and Tissue-Based Products Minimal Manipulation and Homologous Use",Other,,2017-11-17T00:00:00Z,2017,11,,,2024-11-07T01:13:21Z,,0,1,0900006482c8d283